ETV4 and prostate carcinoma: Based on genomic profiles, prostate cancer can be divided into seven molecular subtypes which bear distinct oncogenic drivers including fusions with ETS family members (ERG, ETV1, ETV4, and FLI1) and mutations in SPOP, FOXA1, and IDH1 [29].